Seegene Executive and Leadership Team

Jong-Yoon Chun, the Founder & Chief Executive Officer at Seegene, directs the overarching corporate vision and strategic trajectory of the organization. By prioritizing the development of multiplex molecular technologies, Chun ensures the company maintains a competitive edge in the global clinical diagnostics sector. This leadership role involves constant engagement with the Board to align research initiatives with long-term market expansion goals. Overseeing the integration of M-MoDx solutions, the Founder & Chief Executive Officer drives innovation across all international divisions. Jong-Yoon Chun actively monitors the efficacy of diagnostic platforms to guarantee superior performance standards. Through rigorous oversight of corporate governance and resource allocation, the Founder & Chief Executive Officer secures the financial health of the enterprise. This executive leadership fosters a culture of scientific excellence, positioning the firm as a leader in molecular diagnostics while expanding the reach of advanced testing capabilities across diverse healthcare systems worldwide.

James Yantzi, the President at Seegene, directs the commercial expansion and global business development initiatives for the organization. By overseeing international market penetration, the President ensures that multiplex clinical molecular diagnostics reach a broad spectrum of healthcare institutions. This role involves building strategic partnerships with distributors and clinical laboratories to increase the adoption of M-MoDx technologies. James Yantzi manages the alignment of sales strategies with regional market needs to maximize revenue growth. Through the coordination of marketing and business development teams, the President strengthens the brand presence in competitive global markets. This leadership position requires constant analysis of market data to identify new opportunities for growth and service expansion. By fostering relationships with key stakeholders, the President secures the company's influence within the diagnostic industry. Yantzi drives the commercial success of the firm, ensuring that the business model effectively addresses the evolving needs of the global healthcare community through innovative diagnostic solutions.

Min-Cheol Lee, the Chief Technology Officer at Seegene, architects the research and development roadmap for multiplex molecular diagnostic platforms. By leading the engineering teams, the Chief Technology Officer drives the creation of proprietary technologies that define the company's product portfolio. This role involves evaluating emerging scientific trends to ensure the firm remains at the forefront of molecular diagnostics. Min-Cheol Lee oversees the technical validation of new assays, ensuring compliance with rigorous clinical standards. Through the management of intellectual property and technical innovation, the Chief Technology Officer supports the expansion of the company's diagnostic capabilities. This leadership function requires close collaboration with the executive team to translate complex scientific breakthroughs into scalable commercial products. By optimizing laboratory workflows and testing methodologies, Lee enhances the precision of diagnostic tools. The Chief Technology Officer maintains a focus on technological advancement, ensuring that the firm provides healthcare professionals with the most accurate and efficient molecular testing solutions available.

Daehoon Lee, the Managing Director at Seegene, executes the operational strategies required to scale multiplex clinical molecular diagnostics production. By managing internal workflows and cross-departmental efficiency, the Managing Director ensures that manufacturing processes meet the high-volume demands of global healthcare providers. This role involves coordinating with supply chain partners to maintain consistent output quality across all regional operations. Daehoon Lee optimizes resource utilization to support the rapid deployment of diagnostic kits. Through the implementation of streamlined administrative protocols, the Managing Director enhances organizational agility and responsiveness to market fluctuations. This leadership position requires constant monitoring of operational metrics to identify areas for process improvement. By fostering collaboration between production teams and logistics departments, the Managing Director maintains the integrity of the supply chain. Lee drives the operational excellence necessary to sustain the company's market position, ensuring that diagnostic solutions reach clinical settings with maximum efficiency and reliability.